2026年6月最新影响因子数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
| 热门AI工具: |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐: | 新 Nature期刊平台培训:检索技巧、投稿流程、新刊介绍 | 新 免费报名|9月17日与自然旗下新刊编辑共话脑健康 | 热 全流程投稿协助套餐服务 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Frontiers in Immunology FRONT IMMUNOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.7
184人评分
我要评分
声誉 7.6 影响力 7.3 速度 8.0 | |||||||||||||||||||||
| 期刊ISSN | 1664-3224 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||
| 2025-2026最新IF (数据来源于网友提供) | 注册或登录后,查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:6.95 | |||||||||||||||||||||
| 2025-2026自引率 | 7.1%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF (数据来源于网友提供) | 7.399数据由网友[BlackHunter76]收集提供 | |||||||||||||||||||||
| h-index | 84 | |||||||||||||||||||||
| CiteScore ( 2026年6月最新版) |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://journal.frontiersin.org/journal/immunology
投稿规范预检(避免 Desk Rejection) 开始检查>>
| |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://www.frontiersin.org/submission/submissioninfo.aspx
AI辅助快速完成投稿信初稿 一键撰写投稿信>>
| |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy Author: Zhang, Miao; Yuan, Haibin; Pan, Xindi; Li, Xian; Wang, Zichen; Zhang, Shuping; Gu, Zhigang; Hu, Biao; Qu, Xuedong; Wang, Qian; Gu, Xiangguo; Wang, Bo; Cao, Yu; Mu, Guilin; Kang, Guangbo; de Marco, Ario; Zhou, Xiangshan; Huang, He Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1861537 CTSL loss leads to anti-PD-1 immunotherapy resistance in lung cancer by suppressing the anti-tumor function of peripheral CD8+ T cells Author: Wang, Ying; Huang, Jing; Zou, Xueyang; Xu, Jiancheng Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1863563 Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review Author: Li, Yi-Xiao; Hao, Yan-Lei Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1873528 Soluble IL-2 receptor and memory Treg profiles differentiate early rheumatoid arthritis from undifferentiated arthritis at initial presentation Author: Zi, Xiaoyu; Shi, Yifang; Zhao, Yicong; Gao, Chong; Wang, Caihong Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1844268 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Frontiers in Immunology的语言要求,还能让Frontiers in Immunology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Frontiers in Immunology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(6篇) 论文致谢(13篇) 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD3295; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:immunology、adaptive immunity、innate immunity、clinical immunology、molecular immunology 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015 | |||||||||||||||||||||
| 出版商 | Frontiers Media S.A. | |||||||||||||||||||||
| 涉及的研究方向 | IMMUNOLOGY- | |||||||||||||||||||||
| 出版国家或地区 | SWITZERLAND | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 6551点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 99.90% | |||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 69.99% | |||||||||||||||||||||
| WOS期刊JCR分区 ( 2025-2026年最新版) | 注册或登录后,查看WOS分区等级 | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3224%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 14 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验: | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( USD3295; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Frontiers in Immunology顺利发表。
快看看作者怎么说吧:服务好评(6篇) 论文致谢(13篇) 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy Author: Zhang, Miao; Yuan, Haibin; Pan, Xindi; Li, Xian; Wang, Zichen; Zhang, Shuping; Gu, Zhigang; Hu, Biao; Qu, Xuedong; Wang, Qian; Gu, Xiangguo; Wang, Bo; Cao, Yu; Mu, Guilin; Kang, Guangbo; de Marco, Ario; Zhou, Xiangshan; Huang, He Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1861537 PubMed DOI |
| 2. | CTSL loss leads to anti-PD-1 immunotherapy resistance in lung cancer by suppressing the anti-tumor function of peripheral CD8+ T cells Author: Wang, Ying; Huang, Jing; Zou, Xueyang; Xu, Jiancheng Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1863563 PubMed DOI |
| 3. | Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review Author: Li, Yi-Xiao; Hao, Yan-Lei Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1873528 PubMed DOI |
| 4. | Soluble IL-2 receptor and memory Treg profiles differentiate early rheumatoid arthritis from undifferentiated arthritis at initial presentation Author: Zi, Xiaoyu; Shi, Yifang; Zhao, Yicong; Gao, Chong; Wang, Caihong Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1844268 PubMed DOI |
| 5. | Tetrandrine enhances anti-PD-1 immunotherapeutic efficacy for hepatocellular carcinoma by activating STING/TBK1/IRF3 pathway Author: Zheng, Biao; Yao, Guojun; Pang, Yuli; Luo, Jielong; Yang, Zhiyong; Xiu, Fengmin; Zhen, Chaohui; Liang, Rui Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1850149 PubMed DOI |
| 6. | Theaflavins counteract free fatty acid-driven oxidative-inflammatory injury in endothelial cells through Nrf2-NF-κB axis Author: Zhao, Yufei; Qu, Biao Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1807168 PubMed DOI |
| 7. | Mechanisms and therapeutic prospects of DNA methylation-mucosal innate immunity crosstalk in inflammatory bowel disease Author: Zhang, Tao; Ren, Zhetan; Kang, Zhanshuo; Pan, Zhengchao; Wei, Gang; Wang, Ling; Man, Ru; Peng, Jirun; Yu, Yongduo Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1877804 PubMed DOI |
| 8. | Vaccines as treatment for melanoma: an update review Author: Zhang, Jinjue; Cao, Qing; Cen, Ying; Zhang, Ling; Chen, Junjie Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1724490 PubMed DOI |
| 9. | Epithelial-mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy Author: Yuan, ShaoXiang; Luo, Ziyi; Yang, Nina; Xiong, Tao; Chen, YueZhong; Jian, Xichao; Wang, Yun; Xiao, Shune; Chen, Junzhe; Deng, Chengliang Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1834346 PubMed DOI |
| 10. | Splenic flexure colon cancer may represent a distinct prognostic subtype associated with elevated systemic inflammation and impaired nutritional status Author: Yang, Zhi-Hua; Peng, Yue; Shang, Rong; Tang, Xiao-Yan; Zhou, Yi-Wu; Li, Xiao-Juan; Liao, Yu-Cui Journal: FRONTIERS IN IMMUNOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fimmu.2026.1835428 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共2189条 |
||||||||||||||||
|
|

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室